News
MRNA's second-quarter results are likely to spotlight a sharp decline in Spikevax sales, RSV uptake and key pipeline ...
This risky biotech company faces significant challenges ahead. But it has already proven its worth and may be able to do so ...
Moderna’s LP.8.1-adapted COVID-19 vaccine has been recommended by the European Medicines Agency (EMA)’s human medicines ...
Key Points Moderna has struggled since COVID-19 vaccine demand has shrunk.The stock has correspondingly declined, as revenue has nosedived over the last few years.The long game is clinical trials in ...
1d
Flow Space on MSNIs There Really About to Be a Breast Cancer Vaccine?Sound more like science fiction than actual science? Then, brace yourself because there are, at least, 15 breast cancer vaccine clinical trials in various stages in the U.S., some in phase II and III.
The 'aggressive mandate' of Covid vaccines has been blasted as a 'bad idea' by experts after a new study revealed it saved ...
A series of recent changes could have significant implications for how Americans receive and pay for their shots.
1don MSNOpinion
HHS Secretary RFK Jr. vows to reform the Vaccine Injury Program, highlighting inefficiencies and favoritism in compensating ...
Secretary Robert F. Kennedy Jr. is pledging a major overhaul of the National Vaccine Injury Compensation Program (VICP), ...
Robert F. Kennedy Jr.’s leadership at Health and Human Services has led to changes in vaccine recommendations and access, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results